metforminPapers
Papers about metformin
- papers
- 3,982
Newest first
351 to 400 of 3,982Every paper here, unless its row says otherwiseIndexed under metformin in PubMed; returned by a PubMed search for metformin
Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS.
European journal of cancer (Oxford, England2025PMID 40532471
Rapamycin, Not Metformin, Mirrors Dietary Restriction-Driven Lifespan Extension in Vertebrates: A Meta-Analysis.
Aging cell2025PMID 40532901
Association Between Metformin Use and Mortality Among Individuals With Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort Study.
Journal of immunotherapy (Hagerstown, Md.2025PMID 40548761
Exploring multifaceted roles of metformin in therapeutic applications, mechanistic insights, and innovations in drug delivery systems across biological contexts: a systematic review.
Drug delivery and translational research2025PMID 40555912
Mental state and health-related quality of life in patients with polycystic ovary syndrome under metformin therapy - a prospective study.
Journal of psychosomatic obstetrics and gynaecology2025PMID 40562062
Impact of baseline alanine aminotransferase levels on the efficacy of dapagliflozin and sitagliptin: Latent class analysis from the DIVERSITY-CVR study.
Diabetes, obesity & metabolism2025PMID 40563136Indexed under metformin in PubMed's chemical list
Metformin: A Dual-Role Player in Cancer Treatment and Prevention: A Comprehensive Systematic Review and Meta-Analysis.
Medicina (Kaunas, Lithuania)2025PMID 40572709
Metformin to treat breast cancer: an application of the prevalent new-user design for observational studies with no active comparator.
Journal of clinical epidemiology2025PMID 40578405
The Effect of Metformin Usage in Patients With Metastatic Colorectal Cancer Receiving First-line Systemic Therapy.
In vivo (Athens, Greece)2025PMID 40579038
Comparison of Effects of Dipeptidyl Peptidase-4 Inhibitors and Sulfonylureas in Combination with Metformin: A Hospital-Based Cohort Study of Patients With Type 2 Diabetes.
Clinical therapeutics2025PMID 40579267
Targeting insulin-like growth factor-1 (IGF-1) by using metformin in non-diabetic metastatic breast cancer female patients: a randomized controlled trial.
Cancer chemotherapy and pharmacology2025PMID 40579605
Serum Vitamin B12 Level in Patients with Type 2 Diabetes Mellitus on Metformin Therapy and its Impact on Peripheral Nerve Conduction: A Prospective Study.
Mymensingh medical journal2025PMID 40583685
Metformin and weight loss medication impact on survival outcomes in older women with obesity-related cancers.
Scientific reports2025PMID 40595354
Metformin-improved cognitive impairment in patients with schizophrenia is correlated with activation of tricarboxylic acid cycle and restored functional connectivity of hippocampus.
BMC medicine2025PMID 40597190
Metformin use and risk of colorectal cancer in patients with inflammatory bowel disease: a nationwide, population-based cohort study.
Journal of the National Cancer Institute2025PMID 40601368
Comparative effects of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome: a systematic review and meta-analysis.
Frontiers in endocrinology2025PMID 40607225Also compares against metformin
Association between metformin use and reduced short- and long-term all-cause mortality in patients undergoing cardiac surgery: a retrospective cohort study.
European journal of medical research2025PMID 40635110
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
The Lancet. Oncology2025PMID 40639383
Placental and cerebral circulation in fetuses of mothers with polycystic ovary syndrome and the effect of Metformin exposure.
BMC pregnancy and childbirth2025PMID 40640743
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.
JAMA internal medicine2025PMID 40658388
Metformin use in gestational diabetes is not associated with an increased risk of preterm labor and small for gestational age infants compared to diet control alone.
BMC pregnancy and childbirth2025PMID 40660177
Metformin efficacy and tolerance according to genetic polymorphisms of organic cation transporter 1 in Tunisian patients with type 2 diabetes.
Frontiers in endocrinology2025PMID 40661743
Effect of 40:1 myo-inositol/D-chiro-inositol treatment on serum asprosin levels in polycystic ovary syndrome: a prospective randomized pilot study.
Ginekologia polska2025PMID 40665752Indexed under metformin in PubMed
Metformin's impact on tumor regression grade in diabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy.
Scientific reports2025PMID 40670504
SGLT2 inhibitors vs. metformin for Parkinson's disease risk reduction in type 2 diabetes.
Journal of Parkinson's disease2025PMID 40671477
Risk of severe lower extremity arterial disease in elderly Japanese patients with type 2 diabetes: a propensity score-matched model analysis of sodium-glucose cotransporter 2 inhibitors versus metformin.
BMJ open diabetes research & care2025PMID 40675751
Associations of Metformin Use History With Delirium and Mortality in Patients With Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
Journal of the Academy of Consultation-Liaison Psychiatry2025PMID 40684989
Evaluating GLP-1 receptor agonists versus metformin as first-line therapy for reducing dementia risk in type 2 diabetes.
BMJ open diabetes research & care2025PMID 40695613
The impact of hypoprolactinemia on cardiometabolic effects of metformin in young women: a pilot prospective cohort study.
Journal of endocrinological investigation2025PMID 40711646
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME Study.
The Journal of urology2025PMID 40711960
Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial.
Reproductive biology and endocrinology2025PMID 40713699
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial.
Diabetes, obesity & metabolism2025PMID 40726438
Effects of metformin treatment on the risk of acute myocardial infarction.
Scientific reports2025PMID 40730654
Effects of Metformin on Survival and Toxicity in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab.
Medicina (Kaunas, Lithuania)2025PMID 40731791
Effects of long-term metformin intake on postoperative clinicopathological characteristics in patients with invasive lung adenocarcinoma and type 2 diabetes mellitus: A retrospective analysis.
PloS one2025PMID 40737255
SERUM VITAMIN B12, FOLIC ACID, HOMOCYSTEINE, AND GLYCEMIC CONTROL MARKERS IN PATIENTS WITH TYPE 2 DIABETES BY METFORMIN AND OTHER ORAL ANTIDIABETIC MEDICATIONS.
Georgian medical news2025PMID 40737654
Comparison of the effects of empagliflozin and sitagliptin, as an add-on to metformin, on cardio-metabolic and glycemic parameters of patients with type 2 diabetes mellitus: a randomized, double-blind clinical trial.
BMC research notes2025PMID 40745313
Combining a diet rich in fermentable carbohydrates with metformin improves glycaemic control and reshapes the gut microbiota in people with prediabetes.
Nature metabolism2025PMID 40745466
Metformin Treatment in PCOS Pregnancies Reduces Maternal Infections and Increases the Risk of Allergies and Eczema in the Offspring: Post Hoc Analyses of Two Randomised Controlled Trials and One Follow-Up Study.
BJOG2025PMID 40785326
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trial.
Diabetes, obesity & metabolism2025PMID 40808546Indexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin
Metformin-based oral antihyperglycemic combination therapy and risk of dementia in patients with newly diagnosed type 2 diabetes: A population-based study.
Alzheimer's & dementia2025PMID 40820069
Microneedling-assisted delivery of metformin versus tranexamic acid in treating melasma: a randomized controlled study.
European journal of medical research2025PMID 40826371
Efficacy and Safety of Triple Fixed Dose Combination of Dapagliflozin + Sitagliptin + Metformin IR in Indian Patients with Type 2 Diabetes Mellitus: A Randomized, Phase 3 Study in Comparison with Dual FDC Sitagliptin + Metformin IR.
Advances in therapy2025PMID 40828352
Bioequivalence and Pharmacokinetic Evaluation of Two Metformin Hydrochloride Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers.
European journal of drug metabolism and pharmacokinetics2025PMID 40839056
Efficacy and safety of chiglitazar add-on to metformin in type 2 diabetes mellitus (RECAM study).
Diabetes, obesity & metabolism2025PMID 40842343
Glycaemic responses to metformin monotherapy by SNP clusters in patients with type 2 diabetes.
Diabetes, obesity & metabolism2025PMID 40842374
SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany.
Diabetes, obesity & metabolism2025PMID 40843651Indexed under metformin in PubMed's chemical list
Adding empagliflozin to ongoing metformin improves metabolic profile, tg-g and fib-4 indexes and liver function tests in type 2 diabetic patients with NAFLDS, a clinical trial.
Expert review of endocrinology & metabolism2025PMID 40851544
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial.
The lancet. Diabetes & endocrinology2025PMID 40854315
Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.
Trials2025PMID 40855441